CMIC Co., Ltd.
February 21, 2025 (Founded April 1992)
100 million yen
Shunji Katayama
Development support for pharmaceuticals, medical devices, and regenerative medicine products (regulatory consulting, clinical trials, clinical research and physician-initiated trials, safety information management [pharmacovigilance], post-marketing surveillance, etc.)
Approximately 2,600 (as of March 31, 2026)
BX CMIC CRO Holdings Co., Ltd. (60% owned by Blackstone, 40% by CMIC Holdings)
Class Ⅰ Medical Device Manufacturing and Marketing License, Pharmaceutical Marketing License, Sales and Lease License for Highly Controlled Medical Devices, Registration as an Operator of a Psychotropic Drug Testing and Research Facility, Psychotropic Drug Importer License
ISMS
Founded as Japan’s first CRO (Contract Research Organization)
Began data management and regulatory consulting services
Began monitoring services
Established the Japan CRO Association (as a founding member, we pioneered improving the quality of Japanese clinical trials)
Commenced In Country Clinical Caretaker (ICCC) services
Established a structure supporting all clinical trial functions and expanded the business
Established an offshore center for data management and statistical analysis in Vietnam
Blackstone became a strategic investor (strengthening networks with overseas biotech companies)
For more information about CMIC or to discuss your needs,
click here to contact us.
